News

The locally-backed projects on the Trump Effect list include Diageo, a British alcoholic beverage company, whose $415 million ...
The stocks listed here each increased their dividend payments by more than 10% recently. When you think of a great dividend ...
In a new consensus statement, the European Society of Cardiology has declared vaccinations for common infections to be a ...
Eli Lilly and Johnson & Johnson, PPH’s largest holdings, are facing unique challenges, impacting the ETF’s overall ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Prime Medicine, Inc. achieved strong early data in CGD with PM359, surpassing efficacy thresholds. Click here to find out why ...
Layoffs have become a common business practice, but research shows long-term performance actually declines after layoffs.
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
Eli Lilly is a leader in the weight loss drug market, generating blockbuster revenue. Viking Therapeutics recently launched a phase 3 trial for its weight loss candidate -- and could have a promising ...